Aerie Pharmaceuticals, Inc. Debt Instrument, Face Amount
Aerie Pharmaceuticals, Inc. had Debt Instrument, Face Amount of $316.25 million as of 2020-09-30, per its 10-Q filed 2020-11-06.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2020-11-06
- 2020-09-30: Debt Instrument, Face Amount $316.25M.
- 2020-06-30: Debt Instrument, Face Amount $316.25M.
- 2020-03-31: Debt Instrument, Face Amount $316.25M.
- 2019-12-31: Debt Instrument, Face Amount $316.25M.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2020-09-30 | $316.25M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $316.25M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $316.25M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $316.25M 10-Q · filed 2020-11-06 |
| 2019-09-30 | $316.25M 10-Q · filed 2019-11-07 |
| 2018-06-30 | $125.00M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $125.00M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $125.00M 10-K · filed 2019-03-01 |
| 2017-09-30 | $125.00M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $125.00M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $125.00M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $125.00M 10-K · filed 2018-03-01 |